Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-942
Closed -$211K – 457
2026
Q1
$211K Sell
942
-497
-35% -$124K 0.14% 326
2025
Q4
$347K Buy
+1,439
New +$368K 0.2% 211
2023
Q3
– Sell
-2,232
Closed -$488K – 593
2023
Q2
$488K Sell
2,232
-585
-21% -$130K 0.33% 96
2023
Q1
$617K Buy
2,817
+797
+39% +$173K 0.4% 54
2022
Q4
$420K Buy
+2,020
New +$444K 0.29% 131
2022
Q1
– Sell
-1,116
Closed -$291K – 410
2021
Q4
$291K Buy
+1,116
New +$290K 0.47% 95

Other funds holding RMD

MQS Management's RMD Position: Q2 2026 in Review

MQS Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 942 shares — an estimated $211K sold.

MQS Management first reported a position in RMD in Q4 2021 and held it in 6 quarters. The position peaked at $617K in Q1 2023. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • MQS Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • MQS Management sold 942 ResMed shares in Q2 2026, an estimated $211K.
  • MQS Management first reported a position in ResMed in Q4 2021 and held it in 6 quarters.
  • MQS Management's ResMed position peaked at $617K in Q1 2023.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.